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The distribution and expression of mRNA ene.oding the Ca2"-binding protein regucalcin i  rats were investigated byNorthern blot analys~. Li~ver 
regucalein eDNA (0.6 kb) was used as a prob~. The analyses of total RNAs extracted from various tissues of rat indicated that r~gu~tlcin mRlqA 
was mainly prc~ent in liver but only slightly in kidney with a size of 1.8 kb. The expression level decr~d with increasing age (3, 10 and 25 wc~ks). 
A single intra~riton~i administration f calcium chloride (15 mg Ca/100 g body weight) induced a remarkable increase in regucalcin mRNA in 
liver; the level was about 200% of control at 30 rain after the administration. Sub~quently, the expression level began to decrease with time and 
was about 40% of control evel at 120 rain after the administration. The il~emas~ in regueaicin mRNA levels at 30 rain after calcium administration 
was dos@dependent. These observations show that the expression of regueal¢in mRNA is specific in liver of various tissues, and that it is regulated 
by Ca :" administration. Regu~l¢in may have a role as regulatory protein for calcium homeostasis in liver cells. 
Regucal¢in; Calcium; Gone expression; Northern blot analysis; Rat liver 
1. INTRODUCTION 
Ca ~-+ plays a role as an important second messenger 
signal in a variety of pathways to produce a Ca2*-medi - 
ated physiological response in many cells. The Ca 2÷ 
signal is transmitted to an intracellular response partly 
via a family of calcium-binding proteins [1]. Recently, 
it has been found that a novel calcium-binding protein, 
regucalcin, is distributed in the hepatic eytosol of rats 
[2]. The mol. wt. of regucalcin was estimated to be 
28,800, and the Ca 2+ binding constant was found to be 
4.19 × 105 M -~ by equilibrium dialysis [3]. Regucalein 
has a reversible effect on the activation and inhibition 
of various enzymes by Ca 2+ in liver cells [4--8]. The 
physiological role of regucalein may differ from that of 
ealmodulin in which can amplify the Ca ~+ effect on liver 
metabolism [9]. 
On the other hand, tissue distribution and expression 
of the regucalein gone has not been reported. Therefore, 
the present investigation was undertaken to clarify the 
tissue distribution and regulation of regucalein-messen- 
ger ribonucleic acid (mRNA) by Northern blot analyses 
using hepatic regucalein complementary deoxyribonu- 
cleic acid (eDNA) as a probe. It was found that regueal- 
ein mRNA is mainly distributed in liver, and that the 
expression is increased by the administration of cal- 
eiurn. 
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2, MATERIALS AND METHODS 
2,1. Chemicals 
Deoxyeytidine 5'-[ad2PI triphosphate ([~'~P]dCTP; 110 Tbq/mt'nol) 
and nylon membrane (Hybond N +) for Northern hybridization ~vcre 
obtained from Amersham (Buckinghamshire, UK), A humanp.~tin 
gene fragment (0.43 kb) as an internal standard was obtained ~rom 
Wake Pure Chemical Co. (Omka, Japan). Molecular size standards 
(0.24.-9.5 kb RNA ladder) for el~trophoresis of RNA were pureha~ 
from Beth¢sda Research Laboratories (Gaithersbarg, MD). Calcium 
chlcrid~ and all other reagents were obtained from Sigma Chennical 
Co. (St. Louis, Me)  and Wake Pura Chemical Co. Any water and 
solutions used for RNA preparation were treated with chemical d:ieth- 
ylpyroearbonate (DEPC, Sigma) to inhibit RNa.~ activity. 
2.2. Animal.~' and tissues 
Wistar male rats ofdilTereat ages, purchased from Japan SLC Inc. 
(Hamamatsu, Japan), were fed commercial laboratory chow (solid, 
Oriental Yeast Co., Tokyo) containing 57.5% carbohydrate, 1.1% 
calcium and 1.1% phosphorus and distilled water, freely. 
The following tissues were dissected from rats (3-week-old) to ana- 
lyze the tissue distribution of reguealcin mRNA; cerebrum, eerebel. 
lure, heart, lung, liver, spleen, kidney, skeletal muscle and sracoth 
muscle (diaphragm). Also, 10- and 25-week old rats were u~r.d to 
analyse the expression of regucalcin mRNA during aging. 
2.3. Calehern aakntn~stratlon 
Calcium chloride was dissolved in sterile distilled water at e0m~n- 
trations of 5, i 5 and 30 mg Ca p~r ml. The  solutions were intraper- 
itoneally administcma to rats, At 30, 60 and 126 rain after calcium 
administration, the rats were sacrificed by bleeding. The livers were 
pcrfused with i~.~old 0.25 M suernse solution and immediat~y re. 
moved and frozen at -80°C. Control animals received vehicle solu- 
tion. 
2.4. Isolation of RNA 
Total RNAs were prepared as described [10]. Liver and othe¢ tissues 
were quickly removed, rinsed with ice-cold 0.25 M sucrose solution, 
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and homogenized in buffer solution containing 4 M guanidinium 
thiocyanate, 25 mM sodium citrate (pH 7), 0,5% sareosyl, 0.1 M 
2-mereaptoethanol and 2 M sodium acetate. Total RNAs were ex- 
tracted by vigorous haking in a mixture of phenol, chloroform and 
isoamyl alcohol, and the phases were separated by centrifugation at
10,000 × g for 20 rain at 4"C. RNA located in the aqueous phase was 
precipitated with isopropanol at -20°C. RNA precipitates were pel- 
leted by centrifugation, and the pellets were redissolved in 50/~1 of 
DEPC-treated 0.5% sodium dodecyl sulfate (SDS). 
2.5. Northern blotting 
Ten micrograms of total RNAs extracted from each tissue were 
electrophoresed in 1.2% agarose denaturing els containing 2.2 M 
formaldehyde in MOPS buffer (pH 7, containing 20 mM 3.N-mor- 
pholino-propanesulfonie acid, 5 mM sodium acetate, and 1 mM 
EDTA), applying 3 V/cm for 3 h [11]. The electrophoresed gels were 
transferred to nylon membrane by blotting [11]. Part of reguealcin 
eDNA (a 0.6 kb, Kpnl-Pstl insert) was labeled with [3aP]dCTP by 
random primers with the DNA polymerasc Klenow fragment [12]. 
This radioactive probe was u~,d for hybridization detection of RNAs 
on blots. The membranes were prehybridized, and hybridized in buffer 
solution containing 50% formamide, 5 x SSPE (i x SSPE; 1.15 M 
NaCl, 10 mM NaHaPO4, 1 mM EDTA), 5 x Denhardt's reagent; (1 
x Denhardt's reagent; 0.02% (w/v) each of bovine serum albumin, 
Ficoll and polyvinylpyrrolidine) and 0.5% SDS with 3-'P.labeled 
regucalcin eDNA in a sealed plastic bag at 42°C for 16 h. After 
hybridization the membranes were washed as follows: 2 x SSPE and 
0.1% SDS at 42°C (twice for 15 rain), followed by 0.1 × SSPE and 0.1% 
SDS at room temperature (twice for 15 rain), and then the membranes 
were exposed to X-ray film for 12 h. 
The quantity and integrity of mRNA were monitored by rehy- 
bridizing with a radioactive eDNA probe from the human p-actin gene 
fragment under identical conditions. No noticeable change in the level 
of RNA hybridized with the fl-aetin probe was observed throughout 
the present experiments (data not shown). The size of the hybridizing 
RNA was determined by running the standard RNA molecules of 
known size in parallel. The density of the autoradiographie data was 
quantified by deasitometer scanning (Dual-wavelength Flying-spot 
Scanner, CS-9000, Shimadzu Co., Japan). 
3. RESULTS 
The tissue distribution of regucalcin mRNA in rats 
is shown in Fig. I. In all four types of preparation 
studied, Northern blot analysis using the regucalcin 
eDNA probe showed that regucalcin mRNA was ex- 
pressed in the liver and kidney, while it was not detected 
in the cerebrum, cerebellum, heart, lung, spleen, skeletal 
muscle and smoot muscle (diaphragm). The liver had 
high levels of regucalcin mRNA expression, while the 
kidney contained comparatively low levels. In both tis- 
sues, two distinct mRNA isoforms of 1.8 kb and 1.6 kb 
were seen. The major regucalein mRNA band was 1.8 
kb. 
The alteration of regucalcin mRNA in rat liver with 
increasing age is shown in Fig. 2. With increasing age, 
regucalcin mRNA levels decrease. Regucalcin mRNA 
levels at 25 weeks were about 50% of  that of  3-week-old 
rats. Thus, hepatic regucalcin mRNA levels were re- 
duced with increasing age. 
The effect of  calcium administration on regucalcin 
mRNA in the liver o f  rats is shown in Fig. 3. A solution 
of  calcium chloride (15 m8 Ca/100 g body weight) was 
intraperitoneally administered to rats, and the animals 
i. 8kb 
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Fig. 1. Tissue distribution of regucalcin mRNA levels in rats. Total 
RNA~ (10/~g) inolamd from variou~ tissues in rats were subj~ted to 
Northern blot analysis. The pattern of hybridization obtained with the 
rat liver reguealcin eDNA is shown. Tile arrowheads indicate hy- 
bridizing bands corresponding to mRNA encoding rcguealein. The 
result shows one of four experiments with separate rats. 
were sacrificed at 30, 60 and 120 min after the admini- 
stration. At  30 min after calcium administration, liver 
regucalcin mRNA was markedly increased; the level 
was about  200% of  the control level. Subsequently, the 
mRNA level began to decrease, and it reduced to about  
40% of  the control level at 120 min after the calcium 
administration. Now,  the extracted total RNA content 
was not changed by calcium administration; the RNA 
content was in the range from 0.9 to 1.1 ~g RNA per 
mg wet liver tissue, 
The effect of  increasing doses o f  calcium (5, 15 and 
30 me/100 g) on regucalcin mRNA in the liver o f  rats 
Week 3 I0 25 
i. 8kb  W " 
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Fig. 2. The alteration of ragucalcin mRNA level in the liver of rats with 
increasing age. In each lane 10/zg of total RNA extracted from the 
liver at different ages (3, l0 and 25 weeks) was subjected to Northern 
blot analysis. The pattern of hybridization obtained with the rat liver 
regucalcin eDNA is shown. The arrowhead indicates hybridizing 
bands corresponding to mRNA encoding the regucaicin. The result 
shows one of four ~l~riments with separate rats. 
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Fi$. 3. Effect of calcium administration regu~lcin mRNA levels 
in the liver of rats. Animals received a single intraperitoneal admini- 
stration of calcium (15 rag/100 g). and 30, 60 and 120 rain later they 
were sacrificed by hl~cdlng. Control animals (C) received an equiva- 
lent volume of the distilled water. Total RNA (10/tg) isolat~ from 
the liver were subjected to Northern blot analysis. The pattern of 
hybridization obtained with the rat liver regucalcin eDNA is shown. 
The arrowhead indicates hybridizing bands corresponding to mRNA 
encoding the ree, ucalein, The result shows one of four experiments 
with separate rats. 
is shown in Fig. 4. The liver was removed 30 min after 
a single intraperitoneal dministration of calcium (5, 15 
and 30 mg/100 g). The effect of calcium administration 
on regucalcin mRNA was dose-dependent. Higher 
doses (15 and 30 mg Ca/100 g) produced higher mRNA 
levels. The dose of 30 mg Ca/100 g produced a twofold 
increase over control levels. 
4. DISCUSSION 
A novel calcium-binding protein regucalcin, which 
differs from calmodulin and other calcium-binding pro- 
teins [13-15], is distributed in the hepatic ytosol of  rats 
[2,3]. Reguealcin may play a physiological role in the 
cell different from that of calmodulin, which can am- 
plify the Ca ~- effect on liver metabolism. Regucalcin has 
the reversible ffect of Ca 2+ on many enzymes in the 
hepatic cytosol [4--8]. More recently, it was reported 
that regucalcin can inhibit the activation of Ca2*/cal - 
modulin-dependent cyclic AMP phosphodicsterase [7], 
protein kinase C [5] and Ca'-~'-activated DNA fragmen- 
tation [8] due to binding of Ca ~-÷. 
The present investigation was undertaken to further 
clarify the role of regucalcin by determining the tissue 
distribution of rcgucalcin mRNA in rats. Regucalcin 
mRNA levels in rat tissues were examined by Northern 
blot analyses with a hepatic reguealcin eDNA probe. 
Regucalein mRNA was mainly found in the liver and 
to a slight extent in the kidney, while it was not observed 
1.8kb  w w t 
ICms ~ ~ m  
Fig. 4. The effect of increasing dos~s of ~alcium on regucaicin mRNA 
levels in the liver of rats. Animals received a single intrapcritoncal 
administration f calcium (5, IS and 30 mffl00 g), and 30 rain latgr 
they were sacrificed by bleeding. Control animals (0) received an 
equivalent volume of the distilled water. Total RNAs (10/~g) isolated 
from the liver were subjected toNorthern blot anal>sis. The pattern 
of hybridization btained with the rat liver e~uealcin eDNA is shown. 
The arrowhead indicates hybridizing bands corresponding to mRNA 
encoding the reguealein. The result shows one of four experiments 
with separate rats. 
in brain, heart, lung, spleen and muscles. Most calcium- 
binding proteins are expressed in a number of tissues. 
Calcyclin mRNA is distributed over lung, kidney and 
uterus [16]. The tissue distribution of calcyphosine in- 
eludes thyroid, salivary gland, kidney, lung and brain 
[17]. Thus, regucalcin is characteristic by its specific 
expression in liver. The present results reveal the exis- 
tence of two distinct mRNA isoforms of 1.8 kb and 1.6 
kb, although the 1.6 kb mRNA was only slightly pres- 
ent. These isoforms are thought to be generat.ed by 
alternative splicing of common RNA precursor mole- 
cules; the 1.6 kb mRNA may be an intermediate mole- 
cule of the mature mRNA of regucalcin. Furthermore, 
with increasing age, regucalcin mRNA levels clearly 
decrease. This finding suggests that reguealcin synthesis 
in liver cells may deteriorate with advancing age. 
The effects of Ca "~* on the expression of regucalcin 
mRNA in liver was also investigated. Calcium chlor[Oe 
was administered intraperitoneally to rats using a dose 
of 5-30 mg Ca/100 g. The administration of calcium 
results in a rapid increase in the expression levels of 
mRNA encoding regucalcin in the liver. The increase in 
regucalcin mRNA levels occurred uring the thirty min- 
utes after calcium administration. Thereafter, the levels 
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returned toward• control levels and then decreased to 
less than about 50% of'control evels. From these obser- 
vations, two important implications are assumed. 
Firstly, the expression of regucalcin mRNA rapidly re- 
sponds to calcium administration. Secondly, there may 
bea  regulating system to suppress over-expression of 
the regucalein gene in liver. It has been previously 
shown that a single intraperitoneal administration of" 
calcium chloride (2.0•me/100 g body weight) to rats 
produced a remarkable increase of calcium ,~ontent in 
the liver [18]. Thus, the doses of calcium used were 
sufficient to increase the calcium content in the liver. 
Accordingly, liver calcium may play a role in the expres- 
sion of regucalcin mRNA levels. 
Several steps may be related to the regulation o1" 
regucalcin mRNA levels during the process of post- 
transcription; mRNA stability, translation and post- 
translational events. We have not established whether 
the change in the observed regucalcin mRNA levels is 
due to the transcription process or to mRNA stability. 
Additional studies •designed to directly assess transcrip- 
tional rates and half-live-~ of regucalcin mRNA will be  
necessary. 
In conclusion, it was demonstrated that regucalcin 
mRNA was specifically localized in the liver of rats, and 
• that mRNA levels clearly increased during-the early 
phase of calcium administration. The present findings 
suggest hat regucalcin mRNA expression may be stim- 
ulated by increasing calcium in liver cells. 
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